Acurx Pharmaceuticals Excess Tax Benefit from Stock Compensation (Quarterly) Trends

Acurx Pharmaceuticals, Inc. (ACXP)

2.535 -0.02 (-0.59%) USD | NASDAQ | Jan 21, 16:00

2.535 0.00 (0.00%) After-Hours: 19:51

View Excess Tax Benefit from Stock Compensation (Quarterly) for ACXP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Excess Tax Benefit from Stock Compensation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks

Start Trial

Adial Pharmaceuticals, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	--
Oragenics, Inc.	--